Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase I Pharmacokinetic Study of Intraperitoneal CTEP-Supplied Agent Bortezomib (PS-341, NSC 681239, IND# 58443) and Carboplatin (NSC# 241240) in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer
IRB GOG 9924
CC 13-351
Hospital Hillcrest, Main Campus
Phase Phase 1
Disease Gynecologic
Drug Bortezomib , Carboplatin